@Mal_Itchins Totally unacceptable @Mal_Itchins and it’s terrific that you bravely called it out. By doing so you’re creating a positive, safe atmosphere for all. We should all do this where possible. MDTs should be a safe discussion space so our patients benefit from a variety of opinions.
1/N Finally out!! -- 30Gy for HPV+OPC in @JCO_ASCO
– work by the @MSKCancerCenter Head and Neck team, led by @imrtlee, Eric Sherman, and myself on using hypoxia imaging response to cut treatment 60% (70->30Gy)! #radonc#hncsm https://t.co/zHEaghVres
Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.
awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC@MDAndersonNews@TheLancet@ACKoongMDPhD@StephenVLiu